Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis

Abstract

THE levels and turnover of 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine (DA) suggest that monoaminergic neurones (particularly serotoninergic ones) and their postsynaptic receptors are the main targets of LSD action in man and animals1–4. Because this evidence still seems inconclusive4, we have compared here the effects of LSD with those of lisuride on the biochemistry of brain amines in the rat. Lisuride is an ergot derivative recently introduced for the treatment of migraine, and in oral doses of up to 600 µg, is without hallucinogenic properties in man5. This lack of psychotomimetic effect is unlikely to be due to poor bioavailability after oral administration, because, at least in the rat, oral lisuride was even more effective than after intraperitoneal injection in altering monoamine turnover6. In addition, we have studied the effects of LSD and lisuride after intracerebral injection into the raphe nuclei. The present findings do not support the hypothesis that the hallucinogenic effect of LSD is reflected by variations in the level and turnover of the brain amines. In particular, a stimulation of 5-HT autoreceptors is also evident after the non-hallucinogenic lisuride.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Smith, R. C., Boggan, W. O. & Freedman, D. X. Psychopharmacologia 42, 271–276 (1975).

    Article  CAS  Google Scholar 

  2. Freedman, D. X., Gottlieb, R. & Lovell, R. A. Biochem. Pharmac. 29, 1181–1188 (1970).

    Article  Google Scholar 

  3. Andén, N-E., Corrodi, H., Fuxe, K. & Hökfelt, T. Br. J. Pharmac. 34, 1–7 (1968).

    Article  Google Scholar 

  4. Brawley, P. & Duffield, J. C. Pharmac. Rev. 24, 31–66 (1972).

    CAS  Google Scholar 

  5. Herrmann, W. M. et al. Headache 17, 54–60 (1977).

    Article  CAS  Google Scholar 

  6. Keller, H. H. et al. J. Pharmac. exp. Ther. (in the press).

  7. Kebabian, S. W., Petzold, G. L. & Greengard, P. Proc. natn. Acad. Sci. U.S.A. 69, 2145–2149 (1972).

    Article  ADS  CAS  Google Scholar 

  8. Blumberg, J. B., Taylor, R. E. & Sulser, F. J. Pharm. Pharmac. 27, 125–128 (1975).

    Article  CAS  Google Scholar 

  9. Kehr, W. Eur. J. Pharmac. 41, 261–273 (1977).

    Article  CAS  Google Scholar 

  10. Da Prada, M. et al. Brain Res. 94, 67–73 (1975).

    Article  ADS  CAS  Google Scholar 

  11. Keller, H. H., Burkard, W. P. & Da Prada, M. Experientia 33, 806 (1977).

    Google Scholar 

  12. Keller, H. H. et al. Symp. Dopamine, Southampton (Raven, New York, in the press).

  13. Pieri, M., Schaffner, R. & Haefely, W. Experientia 33, 808 (1977).

    Google Scholar 

  14. Pieri, M. et al. Archs int. Pharmacodyn. Ther. 217, 118–130 (1975).

    CAS  Google Scholar 

  15. Da Prada, M. et al. Ann. N. Y. Acad. Sci. (in the press).

  16. Pieri, L., Pieri, M. & Haefely, W. Nature 252, 586–588 (1974).

    Article  ADS  CAS  Google Scholar 

  17. Aghajanian, G. K. & Haigler, H. J. in Advances in Biochemistry and Psychopharmacology (eds Costa, E., Gessa, G. L. & Sandler, M.) 167–177 (Raven, New York, 1975).

    Google Scholar 

  18. Monachon, M. A., Burkard, W. P., Jalfre, M. & Haefely, W. Archs Pharmac. 274, 192–197 (1972).

    Article  CAS  Google Scholar 

  19. Da Prada, M., Bonetti, E. P. & Keller, H. H. Neurosci. Lett. 6, 349–353 (1977).

    Article  CAS  Google Scholar 

  20. Diab, I. M., Freedman, D. X. & Roth, L. J. Science 173, 1022–1024 (1971).

    Article  ADS  CAS  Google Scholar 

  21. Bennett, J. L. & Aghajanian, G. K. J. Pharm. Pharmac. 28, 516–518 (1976).

    Article  CAS  Google Scholar 

  22. Schmidt, M. J. & Hill, L. E. Life Sci. 20, 789–798 (1977).

    Article  CAS  Google Scholar 

  23. Logan, W. J. in Advances in Neurology (ed. Friendlander, W. J.) 13, 47–72 (Raven, New York, 1975).

    Google Scholar 

  24. Aghajanian, G. K. & Haigler, H. J. Psychopharmac. Commun. 6, 619–629 (1975).

    Google Scholar 

  25. Aghajanian, G. K. Neuropharmacology 15, 521–528 (1976).

    Article  CAS  Google Scholar 

  26. Whitaker, P. M. & Seeman, P. J. Pharm. Pharmac. 29, 506–507 (1977).

    Article  CAS  Google Scholar 

  27. Bennett, J. P. & Snyder, S. H. Molec. Pharmac. 12, 373–389 (1976).

    CAS  Google Scholar 

  28. Snyder, S. H., Faillace, L. & Hollister, L. Science 158, 669–670 (1967).

    Article  ADS  CAS  Google Scholar 

  29. Lloyd, D. Appl. Ther. 12, 19–25 (1970).

    CAS  PubMed  Google Scholar 

  30. Andén, N-E., Roos, B. E. & Werdinius, B. Life Sci. 3, 149–158 (1964).

    Article  Google Scholar 

  31. König, J. F. R. & Klippel, R. A. The Rat Brain: a Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem (Williams & Wilkins, Baltimore, 1963).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

PIERI, L., KELLER, H., BURKARD, W. et al. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis. Nature 272, 278–280 (1978). https://doi.org/10.1038/272278a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/272278a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing